Clinical trials
Hypertension trials in France with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 2 |
| Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | 2 |
| European Georges Pompidou Hospital | 2 |
| University Hospital, Clermont-Ferrand | 2 |
| University Hospital, Grenoble | 2 |
| University Hospital, Strasbourg, France | 2 |
| Groupe Hospitalier Pitie-Salpetriere | 1 |
| Hotel Dieu University Hospital, France | 1 |
| Institute of Cardiometabolism and Nutrition, France | 1 |
| International Society for Vascular Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 24 |
| Diabetes Mellitus | 2 |
| Macular Degeneration | 2 |
| Macular Edema | 2 |
| Retinal Degeneration | 2 |
| Retinitis Pigmentosa | 2 |
| Anemia, Sickle Cell | 1 |
| Atrial Fibrillation | 1 |
| Cognitive Dysfunction | 1 |
| Diabetes, Gestational | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.